Study of a device to manage blood flow in the lungs for heart disease in young children
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at how well a new device works to control blood flow to the lungs in children with heart problems. It reviews medical records of children who had this device placed in their lung arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is 3 years old or younger.
- Child has a congenital or acquired heart condition.
- Child had the device placed in one or both lung arteries between January 2019 and January 2028.
- Parents or guardians gave permission for the child's data to be used.
- This is a review of existing data, not a new treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of replacement valve for children who need a new pulmonary valve (the valve between the heart and lungs). Researchers want to see if the valve works safely and well in real-world use.
This study looks at whether placing a small tube (stent) in a branch pulmonary artery can improve blood flow and heart function after specific childhood heart surgeries. It is meant for people who have d-TGA after ASO, or have ToF or TA, and need a branch PA intervention.
This study tests a personalized breathing technique to improve lung function and heart performance in children who have had heart surgery or are on ECMO. The goal is to find the best way to open up the lungs safely.
This study tests a new non-invasive device called UltraTrac that measures how well the heart pumps blood in people with congenital heart disease. It will be used during standard heart procedures or intensive care stays to see if it works as well as current methods.
This trial tests a special stent for babies with a heart defect that needs a temporary blood vessel to stay open. The stent is placed to help blood flow to the lungs until the baby can have a more permanent surgery.
This study looks at how your heart and lungs respond to starting a blood vessel–widening medication (a vasodilator) for pulmonary hypertension. It will closely monitor your breathing and heart rhythm to help doctors understand and improve treatment.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.